Swiss National Bank Decreases Position in UnitedHealth Group Incorporated $UNH

Swiss National Bank lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 2,614,861 shares of the healthcare conglomerate’s stock after selling 154,200 shares during the quarter. UnitedHealth Group makes up 0.5% of Swiss National Bank’s holdings, making the stock its 25th biggest position. Swiss National Bank’s holdings in UnitedHealth Group were worth $902,912,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth about $25,000. Foster Dykema Cabot & Partners LLC boosted its position in shares of UnitedHealth Group by 69.4% during the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 34 shares during the period. Hurley Capital LLC lifted its stake in shares of UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 40 shares during the last quarter. Sagard Holdings Management Inc. bought a new position in UnitedHealth Group in the 2nd quarter valued at $29,000. Finally, Cloud Capital Management LLC bought a new stake in shares of UnitedHealth Group during the third quarter worth $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.7%

Shares of NYSE UNH opened at $286.86 on Monday. The business has a fifty day moving average price of $308.28 and a 200 day moving average price of $326.02. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The stock has a market capitalization of $260.38 billion, a P/E ratio of 21.75, a price-to-earnings-growth ratio of 1.32 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period in the prior year, the firm posted $6.81 earnings per share. The company’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on UNH. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Morgan Stanley lowered their price target on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a report on Friday, January 23rd. Mizuho dropped their price target on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a research report on Thursday, February 5th. Leerink Partners lowered their price objective on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a research note on Wednesday, January 28th. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $372.13.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.